Overview

Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090

Status:
Active, not recruiting
Trial end date:
2025-07-03
Target enrollment:
Participant gender:
Summary
This is a follow-up study to evaluate the long term outcome of babies treated in the FIREFLEYE study.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Collaborator:
Regeneron Pharmaceuticals
Treatments:
Aflibercept